Adaptive Biotechnologies Corporation (1HM BE) stock market data APIs
€14.3266
-0.21(-1.5%)
as of December 19, 2025
Try our APIs with
free plan!
Adaptive Biotechnologies Corporation Financial Data Overview
Price chart is built with
Anychart
Prev. Close
14.3266
Open
14.118
High
14.3375
Low
14.0967
52 wk Range
5.786-17.945
Market Cap
3 337 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adaptive Biotechnologies Corporation data using free add-ons & libraries
Get Adaptive Biotechnologies Corporation Fundamental Data
Adaptive Biotechnologies Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Adaptive Biotechnologies Corporation End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adaptive Biotechnologies Corporation News
New
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
Adaptive Biotechnologies A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-a...
How Investors Are Reacting To Adaptive Biotechnologies (ADPT) clonoSEQ Data Shaping MRD-Guided Cancer Care
Earlier this month, Adaptive Biotechnologies reported that its clonoSEQ test featured in 90 abstracts at the 67th American Society of Hematology (ASH) Annual Meeting, including 17 studies where next-g...
Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight
ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as J...
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
Adaptive Biotechnologies SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
